# NeuroRx, Inc. — Form D

NeuroRx, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-23. The offering totals $5.5M, of which $4.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-11-23
- Form: D
- Accession: 0001679768-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $4.5M
- Remaining: $1.0M
- Minimum investment: $40K
- Investors: 11
- Date of first sale: 2016-11-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275112

## Issuer

- Name: NeuroRx, Inc.
- CIK: 0001679768
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1201 Orange Street, Suite 600, WILMINGTON, DE, 19801
- Phone: 212-643-0417

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Jonathan Javitt | Director | Bethesda, MD |
| Jonathan Javitt | Executive Officer | Bethesda, MD |
| Chaim Hurvitz | Director | Wilmington, DE |
| James Lawrence | Director | Plymouth, MN |
| Sherry Glied | Director | New York, NY |
| Daniel Javitt | Director | Fort Lee, NJ |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-11-23](https://search.stillhousedata.com/formd/0001679768-16-000003) | D | $2.2M | $2.2M |

## More

- [CIK 1679768 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1679768&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001679768-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.